Bay BH - Search Results

1

The use of Drosophila melanogaster as a model organism to study immune-nanotoxicity.

Ng CT, Yu LE, Ong CN, Bay BH, Baeg GH. Ng CT, et al. Among authors: bay bh. Nanotoxicology. 2019 May;13(4):429-446. doi: 10.1080/17435390.2018.1546413. Epub 2018 Nov 19. Nanotoxicology. 2019. PMID: 30451554 Review.

2

Metabolomics studies show dose-dependent toxicity induced by SiO(2) nanoparticles in MRC-5 human fetal lung fibroblasts.

Huang SM, Zuo X, Li JJ, Li SF, Bay BH, Ong CN. Huang SM, et al. Among authors: bay bh. Adv Healthc Mater. 2012 Nov;1(6):779-84. doi: 10.1002/adhm.201200114. Epub 2012 Aug 28. Adv Healthc Mater. 2012. PMID: 23184831 No abstract available.

3

Drosophila melanogaster as a model organism to study nanotoxicity.

Ong C, Yung LY, Cai Y, Bay BH, Baeg GH. Ong C, et al. Among authors: bay bh. Nanotoxicology. 2015 May;9(3):396-403. doi: 10.3109/17435390.2014.940405. Epub 2014 Jul 22. Nanotoxicology. 2015. PMID: 25051331 Review.

4

Clathrin-mediated endocytosis of gold nanoparticles in vitro.

Ng CT, Tang FM, Li JJ, Ong C, Yung LL, Bay BH. Ng CT, et al. Among authors: bay bh. Anat Rec (Hoboken). 2015 Feb;298(2):418-27. doi: 10.1002/ar.23051. Epub 2014 Oct 3. Anat Rec (Hoboken). 2015. PMID: 25243822 Free article.

5

Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer.

Guo T, Yu Y, Yip GW, Baeg GH, Thike AA, Lim TK, Tan PH, Matsumoto K, Bay BH. Guo T, et al. Among authors: bay bh. Histopathology. 2015 Mar;66(4):491-9. doi: 10.1111/his.12570. Epub 2014 Dec 23. Histopathology. 2015. PMID: 25270600

6

Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.

Scully OJ, Yu Y, Salim A, Thike AA, Yip GW, Baeg GH, Tan PH, Matsumoto K, Bay BH. Scully OJ, et al. Among authors: bay bh. Exp Biol Med (Maywood). 2015 Jul;240(7):846-53. doi: 10.1177/1535370214565075. Epub 2015 Jan 7. Exp Biol Med (Maywood). 2015. PMID: 25573962 Free PMC article.

7

Magnetic vortex nanorings: a new class of hyperthermia agent for highly efficient in vivo regression of tumors.

Liu XL, Yang Y, Ng CT, Zhao LY, Zhang Y, Bay BH, Fan HM, Ding J. Liu XL, et al. Among authors: bay bh. Adv Mater. 2015 Mar 18;27(11):1939-44. doi: 10.1002/adma.201405036. Epub 2015 Feb 5. Adv Mater. 2015. PMID: 25655680 No abstract available.

8

Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.

Shao F, Guo T, Chua PJ, Tang L, Thike AA, Tan PH, Bay BH, Baeg GH. Shao F, et al. Among authors: bay bh. Histopathology. 2015 Nov;67(5):709-18. doi: 10.1111/his.12701. Epub 2015 May 17. Histopathology. 2015. PMID: 25817822

9

Epigenetic mechanisms in nanomaterial-induced toxicity.

Shyamasundar S, Ng CT, Yung LY, Dheen ST, Bay BH. Shyamasundar S, et al. Among authors: bay bh. Epigenomics. 2015;7(3):395-411. doi: 10.2217/epi.15.3. Epigenomics. 2015. PMID: 26077428 Review.

10

Oxidative stress by inorganic nanoparticles.

Tee JK, Ong CN, Bay BH, Ho HK, Leong DT. Tee JK, et al. Among authors: bay bh. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 May;8(3):414-38. doi: 10.1002/wnan.1374. Epub 2015 Sep 10. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016. PMID: 26359790 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page